Pooled 10-donor, male human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.
Pooled 10-donor, mixed-gender human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.
Pooled 50-donor, mixed gender human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.
Pooled 10-donor, female-only human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.
Pooled 20-donor, female-only human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.
Pooled 20-donor male only human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.
-
Formulation - RPMI 1640 MediumComposition of RPMI 1640 (12-918)
-
Formulation - RPMI 1640 MediumComposition of RPMI 1640 (04-525)
-
Formulation - RPMI 1640 Medium (12-167, 08-012)Components present in RPMI 1640 (12-167)
-
Formulation - RPMI 1640 MediumComponents present in RPMI 1640 (12-702)
-
Formulation - RPMI 1640 Medium (BE12-702)Components present in RPMI 1640 (BE12-702)
-
Formulation - RPMI 1640 MediumComponents present in RPMI 1640 (12-115)
-
Formulation - RPMI 1640 MediumComponents present in RPMI 1640 Medium (09-774).
-
TechSheet – RPMI 1640 MediumLonza_BenchGuides_RPMI_1640.pdf
-
Webinar – Efficient Transfection of Biologically Relevant Cells in Immunology Research (pdf)Lonza_Webinars_Webinar__Efficient_Transfection_of_Biologically_Relevant_Cells_in_Immunology_Research.pdf
-
Developing Patient-specific Cell Therapy Manufacturing ProcessesPoster presentation about patient-specific cellular therapies and their tremendous potential for being able to treat life threatening diseases where there are currently no cures.